Skip to search formSkip to main contentSkip to account menu

BHT 3009

Known as: BHT-3009, BHT3009 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Vaccines, DNA

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
Evolution of MS lesions to black holes under DNA vaccine treatment
Persistent black holes (PBH) are associated with axonal loss and disability progression in multiple sclerosis (MS). The objective… 
Review
2010
Review
2010
New drug therapies for multiple sclerosis
Purpose of reviewMultiple sclerosis (MS) is an autoimmune and inflammatory disease of the central nervous system (CNS) that… 
2010
2010
Biological Therapeutics Research and Development--GTCbio's Fifth Annual Conference. October 20-22, 2010, San Francisco, CA, USA.
  • H. Garren
  • IDrugs : the investigational drugs journal
  • 2010
  • Corpus ID: 9851706
The Biological Therapeutics Research and Development--GTCbio's Fifth Annual Conference, held in San Francisco, included topics… 
2009
2009
BHT-3009, a myelin basic protein-encoding plasmid for the treatment of multiple sclerosis.
  • J. CorrealeM. Fiol
  • Current opinion in molecular therapeutics (Print)
  • 2009
  • Corpus ID: 30483064
Even though the etiology of multiple sclerosis (MS) remains largely unknown, research data support the hypothesis that… 
Highly Cited
2008
Highly Cited
2008
Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis
To evaluate the efficacy and safety of BHT‐3009 in relapsing‐remitting multiple sclerosis (MS) and to confirm that BHT‐3009… 
Review
2008
Review
2008
A DNA vaccine for multiple sclerosis
Background: Multiple sclerosis (MS) is a disease in which safety is of paramount importance when developing a potential… 
Review
2008
Review
2008
DNA-based vaccines: the future of multiple sclerosis therapy?
Multiple sclerosis (MS) is the most common human inflammatory, demyelinating and degenerative disorder of the CNS. Based mostly… 
2007
2007
Gateways to clinical trials.
(-)-Epigallocatechin gallate, [188Re]-P2045, 12B75, 89-12; Abacavir sulfate/lamivudine, Abatacept, Abiraterone acetate, ABT-869… 
2006
2006
Gateways to clinical trials.
Gateways to Clinical Trials are a guide to the most recent clinical trials in current literature and congresses. The data in the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)